Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on December 13, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Medoc TSA2 Thermosensory Stimulator System

Closed
NCCIH-2022-00001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection
Solicitation # BARDA-FY27-10192026
The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.
Barda - Aspr / Daappo / Barda Dcma

POSTED

about 17 hours ago

DEADLINE

in 29 days

General Info

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

1

NOI-SSD+final.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → NIH Nci
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Office AddressBethesda, MD, 20892, USA

Full Description

Show more
Requirement Title: Medoc TSA2 Thermosensory Stimulator System Document Type: Notice of Intent/Sources Sought Notice Pre-Solicitation Number: NCCIH-2022-00001 Posted Date: 12/13/2021 Response Date: 12/28/2021 Classification Code: 6640 Laboratory Equipment and Supplies NAICS Code: 334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing Set Aside: No Set-Aside/Unrestricted THIS IS A PRESOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION. Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI), Office of Acquisitions, Riverside Five, Suite 400, 8490 Progress Drive, Frederick, MD 21701, UNITED STATES. Description The National Cancer Institute (NCI) Office of Acquisitions, on behalf of the National Center for Complementary and Integrative Health (NCCIH), intends to negotiate and award a firm-fixed price purchase order on a non-competitive sole source basis for quantity one (1) Medoc TSA2 Thermosensory Stimulator System. The product herein shall be procured in accordance FAR Part 12- Acquisition for Commercial Items and in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1(b)(1) and is exempt from the requirements of FAR Part 6. The resultant award for this commercial product (FAR Part 12) will include all applicable provisions and clauses in effect through Federal Acquisition Circular (FAC) 2022-01 (12/06/2021) and as required by the agency and NCI. Only one award will be made as a result of this pre-solicitation notice. The North American Industry Classification System (NAICS) code is 334510, - Electromedical and Electrotherapeutic Apparatus Manufacturing and the business size standard is 1,250 employees. It has been determined that there are no opportunities to acquire green products or services for this procurement. NCCIH requires quantity one (1) of the Medoc Model MO00015 TSA2 Thermosensory Stimulator System to safely and reliably deliver thermal stimuli to patients. The Medoc TSA2 Thermosensory Stimulator has unique characteristics necessary for NCCIH's research that no other devices possess. These unique characteristics are the following: (1) precise temperature control with a maximum stimulus delivery at any target temperature of 600 seconds so that the device cannot overheat to a level that could injure the participant; (2) fMRI compatible which is essential to ongoing and collaborative NCCIH DIR research that is critical to the NIH mission; (3) portable which allows for bedside testing across the Clinical Center; (4) compatible with existing hardware and software currently used to conduct ongoing studies; (5) the thermal probes, compatible with the Medoc TSA2, are the only probes that have the size specifications that are required to test specific body sites making it essential for testing specific patient populations. The Medoc TSA2 Thermosensory Stimulator is currently the only thermal stimulation device that achieves a better diagnosis with patient safety as a priority. This device has been used in other collaborative projects therefore the same equipment must be used for data continuity purposes. It is in the best interest of the Government to acquire the Medoc TSA2 Thermosensory Stimulator otherwise additional time and money may be needed which would jeopardize the integrity of the research. Contractor shall provide the Medoc Model MO00015 TSA2 Thermosensory Stimulator System and associated components (Quantity 1) with the following Salient Characteristics: Standard TSA2 30x30mm thermode (1 each) TTL input/output triggering Medoc Main Station (MMS) Operating Software External Control (EC) software Dual ports to support 2nd thermode AS00177 Standard TSA2 16x16mm thermode AS00245 Standard CHEPS thermode (24x24mm) Market research revealed that the Cambridge Medical Technologies, Inc. (a division of Medoc Advanced Medical Systems) is the sole provider that can meet the specific requirements needed by NCCIH. Therefore, the Government anticipates a non-competitive award to the Cambridge Medical Technologies, Inc. as they appear to be the only vendor capable of fulfilling the Government's requirement. PLACE OF PERFORMANCE/DELIVERY: The contractor shall deliver the instrument within 30 days from date of award to Bethesda, Maryland 20892. Estimated award date is March 1, 2022. The contractor that receives the award will be provided with the complete mailing address and point of contact. The contractor must contact the point of contact to schedule the delivery date and time. This notice of intent/synopsis is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the above requirement, it may submit a capability statement, proposal or quotation which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 2:00 PM Eastern Time, on December 28, 2021. All responses and questions must be in writing or emailed to Andrew May, Contracting Officer; and Erin Dwyer, Contract Specialist, via electronic mail at andrew.may@nih.gov and erin.dwyer@nih.gov. A determination by the Government not to continue with this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls or facsimiles will be accepted. In order to receive an award, contractors must be registered and have a valid, current Entity Record, including current Representations and Certifications, in the System for Award Management (SAM), through SAM.gov. Reference pre-solicitation number NCCIH-2022-00001 on all correspondence. Primary Points of Contact: Erin Dwyer Contract Specialist erin.dwyer@nih.gov Andrew May Contracting Officer andrew.may@nih.gov Phone: (301) 624-8755

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

NAICS: 622110
Federal
NCI 2026 Cervical Cancer Screening Follow-Up
Solicitation # NCI-SBSS-DCEG-TDRP-0001
The National Cancer Institute (NCI) has issued a Small Business Sources Sought notice, NCI-SBSS-DCEG-TDRP-0001, to identify qualified small business sources for the 2026 Cervical Cancer Screening Follow-Up project. The primary objective is to obtain de-identified clinical and risk factor history and follow-up data for women previously enrolled in cervical cancer screening studies at Kaiser Permanente Northern California. This data, which includes HPV and cytology-based testing, colposcopy, biopsy, and treatment procedures, will be used to generate long-term risk estimates. The acquisition falls under NAICS code 622110 for General Medical and Surgical Hospitals, with a size standard of 47 million dollars. The anticipated period of performance is five years, spanning from January 25, 2027, to January 24, 2032, consisting of a 12-month base year and four 12-month option years. The selected contractor will be required to deliver five annual data sets in .txt, SAS, or EXCEL formats via NCI-approved secure encrypted methods, ensuring compliance with Section 508 ICT accessibility requirements. Additionally, the contractor must participate in quarterly WebEx meetings to review progress. Interested small businesses, including HUBZone, veteran-owned, 8(a), and woman-owned concerns, must submit a tailored capability statement of no more than five pages to the designated contracting officers by 8:00 AM Eastern Time on October 26, 2026.
General Medical and Surgical Hospitals

POSTED

13 days ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS